Literature DB >> 28410146

NOK mediates glycolysis and nuclear PDC associated histone acetylation.

Wei-Ye Shi1, Xiao Yang2, Bo Huang3, Wen H Shen4, Li Liu5.   

Abstract

NOK is a potent oncogene that can transform normal cells to cancer cells. We hypothesized that NOK might impact cancer cell metabolism and histone acetylation. We show that NOK localizes in the mitochondria, and while it minimally impacts tricarboxylic acid (TCA) cycle, it markedly inhibits the process of electron transport and oxidative phosphorylation processes and dramatically enhances aerobic glycolysis in cancer cells. NOK promotes the mitochondrial-nuclear translocation of pyruvate dehydrogenase complex (PDC), and enhances histone acetylation in the nucleus. Together, these findings show that NOK mediates glycolysis and nuclear PDC associated histone acetylation.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28410146     DOI: 10.2741/4572

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  6 in total

Review 1.  Spatiotemporal Control of Acetyl-CoA Metabolism in Chromatin Regulation.

Authors:  Sharanya Sivanand; Isabella Viney; Kathryn E Wellen
Journal:  Trends Biochem Sci       Date:  2017-11-23       Impact factor: 13.807

Review 2.  Metabolic reprogramming and epigenetic modifications on the path to cancer.

Authors:  Linchong Sun; Huafeng Zhang; Ping Gao
Journal:  Protein Cell       Date:  2021-05-29       Impact factor: 15.328

Review 3.  Exploring the Role of ATP-Citrate Lyase in the Immune System.

Authors:  Monica Dominguez; Bernhard Brüne; Dmitry Namgaladze
Journal:  Front Immunol       Date:  2021-02-18       Impact factor: 7.561

4.  Downregulation of GLUT3 impairs STYK1/NOK-mediated metabolic reprogramming and proliferation in NIH-3T3 cells.

Authors:  Weiye Shi; Yu Fu; Yingze Wang
Journal:  Oncol Lett       Date:  2021-05-14       Impact factor: 2.967

5.  Operation of a TCA cycle subnetwork in the mammalian nucleus.

Authors:  Eleni Kafkia; Amparo Andres-Pons; Kerstin Ganter; Markus Seiler; Tom S Smith; Anna Andrejeva; Paula Jouhten; Filipa Pereira; Catarina Franco; Anna Kuroshchenkova; Sergio Leone; Ritwick Sawarkar; Rebecca Boston; James Thaventhiran; Judith B Zaugg; Kathryn S Lilley; Christophe Lancrin; Martin Beck; Kiran Raosaheb Patil
Journal:  Sci Adv       Date:  2022-08-31       Impact factor: 14.957

6.  STYK1/NOK Promotes Metastasis and Epithelial-Mesenchymal Transition in Non-small Cell Lung Cancer by Suppressing FoxO1 Signaling.

Authors:  Yuanyang Lai; Fang Lin; Xuejiao Wang; Jiao Zhang; Jinghua Xia; Ying Sun; Miaomiao Wen; Xiaofei Li; Zhipei Zhang; Jinbo Zhao
Journal:  Front Cell Dev Biol       Date:  2021-07-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.